Chapter/Section Purchase

1 Study Coverage
1.1 Hepatitis B Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Hepatitis B Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Yeast Derived
1.2.3 CHO Derived
1.3 Market by Application
1.3.1 Global Hepatitis B Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hepatitis B Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Hepatitis B Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Hepatitis B Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Hepatitis B Vaccines Sales by Region
2.4.1 Global Hepatitis B Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Hepatitis B Vaccines by Region (2023-2028)
2.5 Global Hepatitis B Vaccines Revenue by Region
2.5.1 Global Hepatitis B Vaccines Revenue by Region (2017-2022)
2.5.2 Global Hepatitis B Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Hepatitis B Vaccines Sales by Manufacturers
3.1.1 Global Top Hepatitis B Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatitis B Vaccines in 2021
3.2 Global Hepatitis B Vaccines Revenue by Manufacturers
3.2.1 Global Hepatitis B Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Hepatitis B Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Hepatitis B Vaccines Revenue in 2021
3.3 Global Hepatitis B Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hepatitis B Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hepatitis B Vaccines Sales by Type
4.1.1 Global Hepatitis B Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Hepatitis B Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Hepatitis B Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Hepatitis B Vaccines Revenue by Type
4.2.1 Global Hepatitis B Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Hepatitis B Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Hepatitis B Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Hepatitis B Vaccines Price by Type
4.3.1 Global Hepatitis B Vaccines Price by Type (2017-2022)
4.3.2 Global Hepatitis B Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Hepatitis B Vaccines Sales by Application
5.1.1 Global Hepatitis B Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Hepatitis B Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Hepatitis B Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Hepatitis B Vaccines Revenue by Application
5.2.1 Global Hepatitis B Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Hepatitis B Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Hepatitis B Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Hepatitis B Vaccines Price by Application
5.3.1 Global Hepatitis B Vaccines Price by Application (2017-2022)
5.3.2 Global Hepatitis B Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Hepatitis B Vaccines Market Size by Type
6.1.1 North America Hepatitis B Vaccines Sales by Type (2017-2028)
6.1.2 North America Hepatitis B Vaccines Revenue by Type (2017-2028)
6.2 North America Hepatitis B Vaccines Market Size by Application
6.2.1 North America Hepatitis B Vaccines Sales by Application (2017-2028)
6.2.2 North America Hepatitis B Vaccines Revenue by Application (2017-2028)
6.3 North America Hepatitis B Vaccines Market Size by Country
6.3.1 North America Hepatitis B Vaccines Sales by Country (2017-2028)
6.3.2 North America Hepatitis B Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Hepatitis B Vaccines Market Size by Type
7.1.1 Europe Hepatitis B Vaccines Sales by Type (2017-2028)
7.1.2 Europe Hepatitis B Vaccines Revenue by Type (2017-2028)
7.2 Europe Hepatitis B Vaccines Market Size by Application
7.2.1 Europe Hepatitis B Vaccines Sales by Application (2017-2028)
7.2.2 Europe Hepatitis B Vaccines Revenue by Application (2017-2028)
7.3 Europe Hepatitis B Vaccines Market Size by Country
7.3.1 Europe Hepatitis B Vaccines Sales by Country (2017-2028)
7.3.2 Europe Hepatitis B Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hepatitis B Vaccines Market Size by Type
8.1.1 Asia Pacific Hepatitis B Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Hepatitis B Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Hepatitis B Vaccines Market Size by Application
8.2.1 Asia Pacific Hepatitis B Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Hepatitis B Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Hepatitis B Vaccines Market Size by Region
8.3.1 Asia Pacific Hepatitis B Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Hepatitis B Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Hepatitis B Vaccines Market Size by Type
9.1.1 Latin America Hepatitis B Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Hepatitis B Vaccines Revenue by Type (2017-2028)
9.2 Latin America Hepatitis B Vaccines Market Size by Application
9.2.1 Latin America Hepatitis B Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Hepatitis B Vaccines Revenue by Application (2017-2028)
9.3 Latin America Hepatitis B Vaccines Market Size by Country
9.3.1 Latin America Hepatitis B Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Hepatitis B Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Hepatitis B Vaccines Market Size by Type
10.1.1 Middle East and Africa Hepatitis B Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Hepatitis B Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Hepatitis B Vaccines Market Size by Application
10.2.1 Middle East and Africa Hepatitis B Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Hepatitis B Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Hepatitis B Vaccines Market Size by Country
10.3.1 Middle East and Africa Hepatitis B Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Hepatitis B Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GSK Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 NCPC
11.2.1 NCPC Corporation Information
11.2.2 NCPC Overview
11.2.3 NCPC Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 NCPC Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 NCPC Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Bio Kangtai
11.4.1 Bio Kangtai Corporation Information
11.4.2 Bio Kangtai Overview
11.4.3 Bio Kangtai Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bio Kangtai Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bio Kangtai Recent Developments
11.5 Dynavax
11.5.1 Dynavax Corporation Information
11.5.2 Dynavax Overview
11.5.3 Dynavax Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Dynavax Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dynavax Recent Developments
11.6 Hissen
11.6.1 Hissen Corporation Information
11.6.2 Hissen Overview
11.6.3 Hissen Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Hissen Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hissen Recent Developments
11.7 KM Biologics
11.7.1 KM Biologics Corporation Information
11.7.2 KM Biologics Overview
11.7.3 KM Biologics Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 KM Biologics Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 KM Biologics Recent Developments
11.8 LG Life Sciences
11.8.1 LG Life Sciences Corporation Information
11.8.2 LG Life Sciences Overview
11.8.3 LG Life Sciences Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 LG Life Sciences Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 LG Life Sciences Recent Developments
11.9 Serum Institute
11.9.1 Serum Institute Corporation Information
11.9.2 Serum Institute Overview
11.9.3 Serum Institute Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Serum Institute Hepatitis B Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Serum Institute Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hepatitis B Vaccines Industry Chain Analysis
12.2 Hepatitis B Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hepatitis B Vaccines Production Mode & Process
12.4 Hepatitis B Vaccines Sales and Marketing
12.4.1 Hepatitis B Vaccines Sales Channels
12.4.2 Hepatitis B Vaccines Distributors
12.5 Hepatitis B Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hepatitis B Vaccines Industry Trends
13.2 Hepatitis B Vaccines Market Drivers
13.3 Hepatitis B Vaccines Market Challenges
13.4 Hepatitis B Vaccines Market Restraints
14 Key Findings in The Global Hepatitis B Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer